Answers are grounded in this paper and cite their sources.
Background Lymphocyte-rich hepatocellular carcinoma (LRHCC) is a rare histologic variant characterized by dense lymphocytic infiltration and a distinct immunologic profile. Although hepatocellular carcinoma is rarely associated with autoimmune neurological complications, the immune-enriched microenvironment of LRHCC may raise the possibility of immune dysregulation. Myasthenia gravis (MG), particularly when accompanied by titin antibody positivity, is classically associated with thymoma as a paraneoplastic phenomenon. Reports of MG associated with hepatocellular carcinoma are very rare. Case presentation We describe an 81-year-old patient who developed progressive respiratory failure and neuromuscular weakness more than one year after curative resection of LRHCC. Initial investigations were inconclusive, however serologic testing revealed strongly positive titin antibodies and high acetylcholine receptor antibody titers, supporting the diagnosis of autoimmune MG. Despite initiation of appropriate treatment for MG, the patient developed progressive hypercapnic respiratory failure and ultimately died. Conclusion This case describes a previously unreported presentation of delayed-onset autoimmune MG and LRHCC. Although a causal relationship cannot be established, it raises questions regarding potential immunologic mechanisms and underscores the importance of considering paraneoplastic autoimmune disease in older patients presenting with new respiratory or neuromuscular symptoms.
No takes yet. Share an insight, caveat, or question.
Xiu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: